Identifying the Respiratory Manifestations of TK2d: The Pulmonologist’s Role
May 14, 2026 - 00:14:45
Radio and PodcastLive Radio & PodcastsHealth
Genetic Pathways in MS: The Clinical Impact of a Chromosome 2 Variant
Guest: Sergio Baranzini, PhD In a landmark study involving over 10,000 patients, the International MS Genetics Consortium (IMSGC) has identified the first genetic variant associated with disease severity in multiple scle...
About This Episode
Genetic Pathways in MS: The Clinical Impact of a Chromosome 2 Variant is an episode from NeuroFrontiers by ReachMD. Guest: Sergio Baranzini, PhD In a landmark study involving over 10,000 patients, the International MS Genetics Consortium (I...
Podcast
This episode belongs to NeuroFrontiers.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Sep 29, 2025, 00:05:30 long, audio available.
Related Episodes
Continue listening to more episodes from NeuroFrontiers.
Recognizing TK2d: Key Clinical Signs and Diagnostic Protocols
May 14, 2026 - 00:13:30
Understanding Variability in Myasthenia Gravis
May 1, 2026 - 00:03:45
Examining the Global Genetic Prevalence of TK2d
Apr 30, 2026 - 00:14:01
Advances in Cell-Based Therapy for MS
Apr 20, 2026 - 00:03:15
Next-Generation MS Care: The Promise of Cell-Based Therapeutics
Apr 20, 2026 - 00:03:00
Applying the 2024 McDonald Criteria: Real-World Impacts on MS Diagnosis
Mar 30, 2026 - 00:03:00
Proactive Pregnancy Planning and Reproductive Care in MS
Mar 30, 2026 - 00:03:00
Questions About This Episode
What is Genetic Pathways in MS: The Clinical Impact of a Chromosome 2 Variant about?
Guest: Sergio Baranzini, PhD In a landmark study involving over 10,000 patients, the International MS Genetics Consortium (IMSGC) has identified the first genetic variant associated with disease severity in multiple sclerosis (MS). Dr. Sergio Baranzini, a Distinguished Professor of Neurology at the University of California, San Francisco Weill Institute for Neurosciences, explains what's next in researching this variant and working towards effective treatments. Dr. Baranzini also spoke on this topic at the 2025 Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).
Where can I listen to Genetic Pathways in MS: The Clinical Impact of a Chromosome 2 Variant?
You can listen to Genetic Pathways in MS: The Clinical Impact of a Chromosome 2 Variant online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is Genetic Pathways in MS: The Clinical Impact of a Chromosome 2 Variant from?
Genetic Pathways in MS: The Clinical Impact of a Chromosome 2 Variant is an episode from NeuroFrontiers by ReachMD.
How long is this episode?
This episode is 00:05:30 long.
When was this episode published?
This episode was published on Sep 29, 2025.
Can I save Genetic Pathways in MS: The Clinical Impact of a Chromosome 2 Variant for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from NeuroFrontiers?
Yes. This page shows related episodes from NeuroFrontiers when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to Genetic Pathways in MS: The Clinical Impact of a Chromosome 2 Variant?
You can listen to Genetic Pathways in MS: The Clinical Impact of a Chromosome 2 Variant on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
Genetic Pathways in MS: The Clinical Impact of a Chromosome 2 Variant is from NeuroFrontiers by ReachMD.
What are the episode details?
Published Sep 29, 2025 and 00:05:30 long